BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 30, 2015
View Archived Issues
Bcl-2-like protein 11 is directly involved in beta cell apoptosis
Read More
TALENs used to disrupt gene for Rhesus D antigen in erythroid progenitor cells
Read More
Afferent Pharmaceuticals reports results from phase IIb trial of AF-219 in chronic cough
Read More
MPS1 inhibitor S-81694 begins first-in-human study for solid tumors
Read More
Advaxis initiates phase I study of ADXS-HER2 for HER2-expressing solid tumors
Read More
Aduro Biotech to acquire BioNovion
Read More
MedImmune and 3M Drug Delivery Systems collaborate to develop next-generation TLR agonists
Read More
Intercept Pharmaceuticals starts phase III trial of obeticholic acid in NASH with fibrosis
Read More
Verona releases data on new suspension formulation of RPL-554 in patients with COPD
Read More
FDA confirms data needed for Medidur NDA filing
Read More
BioMarin starts phase I/II trial of hemophilia A gene therapy BMN-270
Read More
Ablynx starts phase III trial of caplacizumab in acquired TTP
Read More
PDE4D is involved in Hedgehog signaling and could be targeted to treat medulloblastoma
Read More
CFTR gene therapy is associated with stabilization of lung function in phase IIb CF trial
Read More
F2G reports PK/PD profile of novel orotomide antifungal F-901318
Read More
IURTC and Assembly Biosciences patent HBV core protein allosteric modulators
Read More
Department of Health of the U.K. and JNCASR describe antimicrobial conjugates
Read More
Principia Biopharma reports TXK and ITK inhibitors
Read More
Merck & Co. and Merck Frosst Canada report HIV protease inhibitors
Read More
Takeda submits NDA for fixed-dose combination of Nesina and metformin in Japan
Read More
Endo confirms termination of waiting period for Par Pharmaceutical acquisition
Read More
Circulating miRNA levels associated with insulin resistance in metabolic syndrome
Read More
Maruho's Zebiax approved in Japan for bacterial skin infections
Read More
Topline results from third phase III trial of baricitinib for rheumatoid arthritis
Read More
Promising outcome in phase III ORATORIO study of ocrelizumab in primary progressive MS
Read More
FDA and EMA accept filings for rociletinib for NSCLC
Read More